Literature DB >> 22310682

CD4+ T cells limit the damage in influenza.

Anne Kelso.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22310682     DOI： 10.1038/nm.2654

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  15 in total

1.  Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus.

Authors:  Katherine A Richards; David Topham; Francisco A Chaves; Andrea J Sant
Journal:  J Immunol       Date:  2010-10-01       Impact factor: 5.422

2.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Authors:  Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

3.  Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

Authors:  Suzanne L Epstein
Journal:  J Infect Dis       Date:  2005-11-21       Impact factor: 5.226

Review 4.  Immune responses to influenza virus infection.

Authors:  J H C M Kreijtz; R A M Fouchier; G F Rimmelzwaan
Journal:  Virus Res       Date:  2011-09-22       Impact factor: 3.303

5.  Limited human-to-human transmission of novel influenza A (H3N2) virus--Iowa, November 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-02       Impact factor: 17.586

Review 6.  Cross-protective immunity to influenza A viruses.

Authors:  Suzanne L Epstein; Graeme E Price
Journal:  Expert Rev Vaccines       Date:  2010-11       Impact factor: 5.217

7.  Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.

Authors:  J H C M Kreijtz; G de Mutsert; C A van Baalen; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

8.  Cytotoxic T-cell immunity to influenza.

Authors:  A J McMichael; F M Gotch; G R Noble; P A Beare
Journal:  N Engl J Med       Date:  1983-07-07       Impact factor: 91.245

9.  Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans.

Authors:  Erika Assarsson; Huynh-Hoa Bui; John Sidney; Qing Zhang; Jean Glenn; Carla Oseroff; Innocent N Mbawuike; Jeff Alexander; Mark J Newman; Howard Grey; Alessandro Sette
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

10.  Declining T-cell immunity to influenza, 1977-82.

Authors:  A J McMichael; F M Gotch; D W Dongworth; A Clark; C W Potter
Journal:  Lancet       Date:  1983-10-01       Impact factor: 79.321
View more
  4 in total

1.  Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV.

Authors:  Chih-Wei Lin; Ching-Yun Chang; Wei-Lin Chen; Shih-Chang Lin; Chien-Chun Liao; Jui-Yuan Chang; Chia-Chyi Liu; Alan Yung-Chih Hu; Tsung-Chun Lu; Ai-Hsiang Chou; Suh-Chin Wu; Pele Chong; Ming-Hsi Huang
Journal:  Hum Vaccin Immunother       Date:  2013-07-09       Impact factor: 3.452

2.  Dynamic causal modelling of immune heterogeneity.

Authors:  Thomas Parr; Anjali Bhat; Peter Zeidman; Aimee Goel; Alexander J Billig; Rosalyn Moran; Karl J Friston
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.379

3.  CD206+ cell number differentiates influenza A (H1N1)pdm09 from seasonal influenza A virus in fatal cases.

Authors:  Heidi G Rodriguez-Ramirez; Mario C Salinas-Carmona; Oralia Barboza-Quintana; Americo Melo-de la Garza; Luis Angel Ceceñas-Falcon; Lilia M Rangel-Martinez; Adrian G Rosas-Taraco
Journal:  Mediators Inflamm       Date:  2014-11-25       Impact factor: 4.711

4.  Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older.

Authors:  Robert B Couch; José M Bayas; Covadonga Caso; Innocent Nnadi Mbawuike; Concepción Núñez López; Carine Claeys; Mohamed El Idrissi; Caroline Hervé; Béatrice Laupèze; Lidia Oostvogels; Philippe Moris
Journal:  BMC Infect Dis       Date:  2014-07-30       Impact factor: 3.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.